IntelGenx (TSXV:IGX; OTCQX:IGXT) updated its cannabis-infused VersaFilm product co-development program with Tilray (NASDAQ:TLRY), following recently proposed Government of Canada amendments to the Cannabis Act that...
Echelon Wealth Partners reiterated Profound Medical’s Top Pick status (TSX:PRN; OTCQX:PRFMF) and maintained its “buy” rating and $3 price target. The stock closed at 74 cents on Jan. 9. Analyst Doug Loe writes that...
Closely-held Fibrocor Therapeutics, and Galapagos NV (Euronext, NASDAQ:GLPG), of Belgium formed a partnership for the development of therapeutics to treat fibrotic diseases of the kidney and other organs. In 2017, MaRs...
Following passage of the U.S. 2018 Farm Bill, Canopy Growth (NYSE:CGC;TSX: WEED) provided an update of its hemp operations and expanded pathways to the American market for hemp-based products, including CBD products...
Profound Medical (TSX:PRN; OTCQX:PRFMF) expects total revenue of about $1.6-million for the fourth quarter of 2018, up from about $300,000 for the third quarter last year. For all of 2018, the company expects total...
Closely-held Scientus Pharma received authorization under Health Canada’s cannabis regulations for the sale of cannabis for medical purposes and to modify its processor licence to sell dried and fresh cannabis products...
BeyondSpring (NASDAQ:BYSI) had a positive pre-NDA meeting with the FDA about its lead asset, Plinabulin. The focus of this meeting was the content of the chemistry, manufacturing and control (CMC) sections of the...
BeyondSpring (NASDAQ:BYSI) received a new composition of matter patent for its lead asset, Plinabulin, from the U.S. Patent and Trademark Office. As a polymorph, Pinabulin can be converted into multiple crystalline...
Canopy Rivers (TSXV:RIV) announced that NETA NJ LLC, a company controlled by its portfolio company, TerrAscend (CSE:TER; OTCQX:TRSSF), has been selected by the State of New Jersey Department of Health to apply for final...
IntelGenx (TSX-V:IGX; OTCQX:IGXT) signed a definitive licensing, development and supply agreement with Gensco Pharma, a specialty pharmaceutical company, for the exclusive commercialization of RIZAPORT in the U.S. “With...